Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Tugba Gokce"'
Autor:
Kagan Ege Karakuş, Tugba Gokce, Serra Muradoğlu, Ecem Can, Elif Eviz, Gül Yeşiltepe Mutlu, Şükrü Hatun
Publikováno v:
Clinical Diabetology. 12:53-59
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c3a5af56a454b9a9c37abec59534748
https://doi.org/10.5603/dk.a2022.0066
https://doi.org/10.5603/dk.a2022.0066
Publikováno v:
Clinical Diabetology. 12:45-52
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2403cb96a9cc062fc370dd12e4ac8344
https://doi.org/10.5603/dk.a2022.0063
https://doi.org/10.5603/dk.a2022.0063
Publikováno v:
Journal of Pediatric Endocrinology and Metabolism. 35:611-616
Background Unlike in Western countries, the use of diabetes technologies has been limited in Turkey, or at least until the last few years. This low adoption frequency may be attributed to the lack of experience of pediatric diabetes teams in working
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::598fe0b42dab84cfe4aa912cddd3565e
https://doi.org/10.1515/jpem-2022-0024
https://doi.org/10.1515/jpem-2022-0024
Autor:
Şükrü Hatun, Tuğba Gökçe, Ecem Can, Elif Eviz, Kağan Ege Karakuş, Carmel Smart, Ragnar Hanas, Gül Yeşiltepe Mutlu
Publikováno v:
JCRPE, Vol 16, Iss 3, Pp 245-255 (2024)
Successful management of type 1 diabetes (T1D) requires not only optimal glycemic outcomes, but also a holistic approach that encompasses all aspects of life and recommendations to address needs. Current goals include optimal glycemic values, quality
Externí odkaz:
https://doaj.org/article/8ee2b919b7be4df281dc8c156a67c9b4
Autor:
Şükrü Hatun, Buket Dalgıç, Damla Gökşen, Sema Aydogdu, Şenay Savaş Erdeve, Zarife Kuloğlu, Yaşar Doğan, Zehra Aycan, Gül Yeşiltepe Mutlu, Nuray Uslu Kızılkan, Alev Keser, Ömer Faruk Beşer, Mehmet Nuri Özbek, Aysun Bideci, Deniz Ertem, Olcay Evliyaoğlu, Beyza Eliuz Tipici, Tuğba Gökçe, Serra Muradoğlu, Orhun Çığ Taşkın, Tuğba Koca, Filiz Tütüncüler, Firdevs Baş, Feyza Darendeliler, Mukadder Ayşe Selimoğlu
Publikováno v:
JCRPE, Vol 14, Iss 1, Pp 1-9 (2022)
It is well-known that in children with type 1 diabetes (T1D), the frequency of Celiac disease (CD) is increased due to mechanisms which are not fully elucidated but include autoimmune injury as well as shared genetic predisposition. Although histopat
Externí odkaz:
https://doaj.org/article/ebf94e0f56414df49390df3e2ddb8cd4
Autor:
Şükrü Hatun, Gül Yeşiltepe Mutlu, Tuğba Gökçe, Özkan Avcı, Nazan Yardım, Zehra Aycan, Feyza Darendeliler
Publikováno v:
JCRPE, Vol 13, Iss 4, Pp 370-374 (2021)
Diabetes care at school has recently appeared on the agenda of international diabetes organizations, the basic principles of which have been newly determined. The aim of this review was to summarize the activities and output of the Diabetes at School
Externí odkaz:
https://doaj.org/article/e27aad58589f46e2901810cf778724c4
Publikováno v:
JCRPE, Vol 13, Iss 3, Pp 285-292 (2021)
Objective:Hypoglycemia is a common acute complication of type 1 diabetes (T1D), which may cause seizure, loss of consciousness, and temporary motor or sensory impairment. Glucagon administration is an effective way of treating severe hypoglycemia, es
Externí odkaz:
https://doaj.org/article/953ec7fcb63541919a701220b0d9808d
Autor:
Gül Yeşiltepe-Mutlu, Merve Çapacı, Ecem Can, Tuğba Gökçe, Gizem Bayrakçı, Serra Muradoğlu, Said İncir, Esra Papatya Çakır, Şükrü Hatun
Publikováno v:
BMC Endocrine Disorders, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Currently, there is a lack of data relating to glycemic parameters and their relationship with C-peptide (CP) and proinsulin (PI) during the partial remission period (PRP) in type 1 diabetes mellitus (T1D). The aim of this study w
Externí odkaz:
https://doaj.org/article/7c7969fcc360420082757787c8bae1c0
Autor:
Şükrü Hatun, Gül Yeşiltepe Mutlu, Tuğba Gökçe, Ecem Can, Serra Muradoğlu, Elif Eviz, Kardelen Cemhan
Publikováno v:
JCRPE, Vol 13, Iss 2, Pp 245-247 (2021)
Externí odkaz:
https://doaj.org/article/0abd8f8eb3244783937bc680ca6b2c14
Autor:
Kağan Ege Karakuş, Sibel Sakarya MD, MPH, Gül Yeşiltepe Mutlu MD, Metehan Berkkan, Serra Muradoğlu MA, Ecem Can MSN, RN, Tuğba Gökçe BSN, Elif Eviz MD, Şükrü Hatun MD
Publikováno v:
Journal of Patient Experience, Vol 8 (2021)
Investigating the daily life experiences of patients using Continuous Glucose Monitoring (CGM) can highlight the benefits and barriers in using this system for people with type 1 diabetes (T1D). Semi-structured qualitative interviews were conducted w
Externí odkaz:
https://doaj.org/article/552d601abcef4f5db01bbda5719b9c4b